Cargando…
The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
The transplantation of Wharton’s jelly derived mesenchymal stromal cells (WJ-MSCs) possesses therapeutic potential for the treatment of a spinal cord injury (SCI). Generally, the main effect of MSCs is mediated by their paracrine potential. Therefore, application of WJ-MSC derived conditioned media...
Autores principales: | Chudickova, Milada, Vackova, Irena, Machova Urdzikova, Lucia, Jancova, Pavlina, Kekulova, Kristyna, Rehorova, Monika, Turnovcova, Karolina, Jendelova, Pavla, Kubinova, Sarka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770545/ https://www.ncbi.nlm.nih.gov/pubmed/31547264 http://dx.doi.org/10.3390/ijms20184516 |
Ejemplares similares
-
The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application
por: Krupa, Petr, et al.
Publicado: (2018) -
A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential
por: Petrenko, Yuriy, et al.
Publicado: (2020) -
4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats
por: Štěpánková, Kateřina, et al.
Publicado: (2023) -
Clinically Relevant Solution for the Hypothermic Storage and Transportation of Human Multipotent Mesenchymal Stromal Cells
por: Petrenko, Yuriy, et al.
Publicado: (2019) -
Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury
por: Štepánková, Kateřina, et al.
Publicado: (2023)